Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641281-25-000007
Filing Date
2025-08-14
Accepted
2025-08-14 16:09:03
Documents
61
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bolt-20250630.htm   iXBRL 10-Q 2207341
2 EX-31.1 bolt-ex31_1.htm EX-31.1 14694
3 EX-32.1 bolt-ex32_1.htm EX-32.1 7641
  Complete submission text file 0001641281-25-000007.txt   8596974

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20250630.xsd EX-101.SCH 930691
63 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20250630_htm.xml XML 1850476
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39988 | Film No.: 251218986
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)